SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-070834
Filing Date
2024-06-12
Accepted
2024-06-12 16:08:25
Documents
14
Period of Report
2024-06-12
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2417037d1_8k.htm   iXBRL 8-K 29733
  Complete submission text file 0001104659-24-070834.txt   253998

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA brns-20240612.xsd EX-101.SCH 3545
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE brns-20240612_def.xml EX-101.DEF 26916
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE brns-20240612_lab.xml EX-101.LAB 36969
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE brns-20240612_pre.xml EX-101.PRE 25540
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2417037d1_8k_htm.xml XML 5623
Mailing Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF
Business Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF 44 (0) 1865 818808
Barinthus Biotherapeutics plc. (Filer) CIK: 0001828185 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40367 | Film No.: 241038470
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)